Closed-loop Synchronization Versus Conventional Synchronization
Launched by DR. BEHCET UZ CHILDREN'S HOSPITAL · Feb 15, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to help children who need breathing support with a machine called a ventilator. One method is called closed-loop synchronization, which automatically adjusts the ventilator to better match the child's natural breathing. The other method is conventional synchronization, which is the standard way we currently manage ventilator settings. The goal is to see which method is safer and more effective for children with serious breathing issues in the pediatric intensive care unit (PICU).
To be eligible for this study, children must be between 1 month and 18 years old and need mechanical ventilation for at least the next three hours. A parent or guardian must provide written consent for their child to participate. If a child joins the study, they can expect to receive either the new closed-loop method or the standard method of ventilation. It's important to note that this study is only for children who are stable and not facing critical situations that could prevent them from participating. Overall, this trial aims to improve how we support young patients with respiratory problems and help them breathe better while they are receiving care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients older than 1 month and younger than18 years of age
- • Hospitalized at the PICU with the intention of treatment with mechanical ventilation at least for the upcoming 3 hours with spontaneous breathing activity
- • Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation
- Exclusion Criteria:
- • Formalized ethical decision to withhold or withdraw life support
- • Patient included in another interventional research study under consent
- • Patient already enrolled in the present study in a previous episode of respiratory failure
- • Pregnant woman
- • Patients deemed at high risk for the need of transportation from PICU to another ward, diagnostic unit or any other hospital
- • Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h
- • Not being able to obtain reference waveform
About Dr. Behcet Uz Children's Hospital
Dr. Behcet Uz Children's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and comprehensive medical care. With a strong emphasis on evidence-based practices, the hospital engages in a variety of clinical trials aimed at improving treatment outcomes for children with diverse medical conditions. The institution is committed to fostering a collaborative research environment, leveraging its experienced medical staff and state-of-the-art facilities to ensure the highest standards of patient safety and ethical conduct in all trials. Through its efforts, Dr. Behcet Uz Children's Hospital strives to contribute significantly to the field of pediatric medicine and enhance the quality of life for children and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, , Turkey
Izmir, , Turkey
Aydın, , Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Hasan Agin, Professor
Principal Investigator
Behcet Uz Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials